PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 60 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | -83.3% | 324 | -95.4% | 0.00% | – |
| Q3 2019 | $6,000 | 0.0% | 6,999 | +9.0% | 0.00% | – |
| Q2 2019 | $6,000 | -98.4% | 6,419 | -97.9% | 0.00% | – |
| Q1 2019 | $380,000 | +239.3% | 301,269 | +775.8% | 0.00% | – |
| Q4 2018 | $112,000 | +187.2% | 34,398 | +113.3% | 0.00% | – |
| Q3 2018 | $39,000 | -2.5% | 16,127 | +11.6% | 0.00% | – |
| Q2 2018 | $40,000 | -84.7% | 14,452 | -73.7% | 0.00% | – |
| Q1 2018 | $261,000 | +2075.0% | 54,957 | +2396.9% | 0.00% | – |
| Q4 2017 | $12,000 | -85.7% | 2,201 | -87.7% | 0.00% | – |
| Q2 2017 | $84,000 | -45.1% | 17,861 | -8.7% | 0.00% | – |
| Q1 2017 | $153,000 | +7550.0% | 19,564 | +10036.8% | 0.00% | – |
| Q4 2016 | $2,000 | -86.7% | 193 | -79.4% | 0.00% | – |
| Q3 2016 | $15,000 | – | 939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,350,000 | $36,636,000 | 4.04% |
| EcoR1 Capital, LLC | 602,315 | $9,390,000 | 2.88% |
| NEA Management Company, LLC | 3,556,778 | $55,450,000 | 2.49% |
| Opaleye Management Inc. | 152,000 | $2,370,000 | 1.24% |
| Avoro Capital Advisors LLC | 179,565 | $2,799,000 | 0.49% |
| Monashee Investment Management LLC | 85,000 | $1,325,000 | 0.47% |
| Rock Springs Capital Management LP | 450,000 | $7,016,000 | 0.44% |
| Perceptive Advisors | 344,550 | $5,372,000 | 0.35% |
| Hillhouse Capital Management | 763,790 | $11,907,000 | 0.24% |
| Eventide Asset Management | 220,000 | $3,430,000 | 0.21% |